--- title: "Power On: SkyWater’s Quantum Leap and Nakamoto’s Bitcoin Pivot" type: "News" locale: "en" url: "https://longbridge.com/en/news/293012512.md" description: "Mid-2026 is defined by extreme corporate pivots. SkyWater Technology is merging with IonQ to reshape quantum hardware, while Nakamoto Inc closes its medical clinics to go all-in on Bitcoin. Here is what else you need to know." datetime: "2026-07-17T09:11:51.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293012512.md) - [en](https://longbridge.com/en/news/293012512.md) - [zh-HK](https://longbridge.com/zh-HK/news/293012512.md) --- # Power On: SkyWater’s Quantum Leap and Nakamoto’s Bitcoin Pivot Welcome to another look at the shifting landscape of tech, bio, and energy. If there is one overarching theme taking hold in mid-2026, it is the radical corporate pivot. Companies are no longer content with incremental growth; they are tearing up their legacy business models to chase the next massive wave. The biggest structural shakeup we are tracking right now is happening in the foundry space. SkyWater Technology (SKYT.US) has officially secured shareholder approval for its merger with IonQ, an ambitious deal slated to close in the coming months. Coming off a record-breaking 2025 driven by the Fab 25 acquisition, SkyWater is leveraging its robust traditional IC manufacturing base to embed itself directly into the quantum computing supply chain. It is a massive transition that could redefine domestic hardware manufacturing. Speaking of massive transitions, Nakamoto Inc (NAKA.US) has completely abandoned its past. As of June, the company officially shut down its final legacy medical clinic, finalizing its transformation into a pure-play Bitcoin operation. To survive the pivot, the company has had to pull every financial lever available—from selling off roughly 600 Bitcoin to clear $45 million in debt, to initiating a 1-for-40 reverse stock split to dodge Nasdaq delisting. It is a high-wire act, but the balance sheet restructuring is now complete. Over in the regulatory and clinical pipeline, major milestones are being crossed. Biohaven Pharmaceutical (BHVN.US) closed out June by completing enrollment for its critical RISE 3 study for focal epilepsy, right alongside kicking off Phase 3 trials for Graves' disease. Meanwhile, Tvardi Therapeutics (TVRD.US) rolled out positive Phase 1 data for its oral STAT3 inhibitor in July, setting the stage for what will be a make-or-break Phase 2 data drop later this year. On the infrastructure front, the domestic nuclear narrative continues to solidify. Uranium producer enCore Energy Corp (EU.US) just secured its ultimate regulatory victory: a full NRC license for its Dewey Burdock project, cementing its position in the domestic clean energy supply chain. **Here is the rundown of everything else you need to know:** - **Healthcare AI push:** Healthcare Triangle Inc (HCTI.US) is riding high on massive Q1 revenue growth and just secured $3.6 million in private financing in June to fuel the global expansion of its AI-driven mental health platform, ZoraNex. - **Reverse splits and survival:** Hong Kong-based financial services provider Garden Stage Limited (GSIW.US) finally regained Nasdaq compliance this spring after executing a drastic 200-for-1 reverse split to cure its long-standing bid price deficiencies. - **Holding steady:** Outside the tech frenzy, European frozen food giant Nomad Foods Limited (NOMD.US) and Japanese specialized legal tech player Robot Consulting Co Ltd (LAWR.US) continue to navigate their respective niche markets quietly, focusing on core operations amid shifting consumer and enterprise spending habits. ### Related Stocks - [SKYT.US](https://longbridge.com/en/quote/SKYT.US.md) - [NAKA.US](https://longbridge.com/en/quote/NAKA.US.md) - [BHVN.US](https://longbridge.com/en/quote/BHVN.US.md) - [TVRD.US](https://longbridge.com/en/quote/TVRD.US.md) - [GSIW.US](https://longbridge.com/en/quote/GSIW.US.md) - [HCTI.US](https://longbridge.com/en/quote/HCTI.US.md) - [NOMD.US](https://longbridge.com/en/quote/NOMD.US.md) - [LAWR.US](https://longbridge.com/en/quote/LAWR.US.md) ## Related News & Research - [Biohaven Ltd. $BHVN Shares Bought by Quantinno Capital Management LP](https://longbridge.com/en/news/296018014.md) - [Nomad Foods (NOMD) Q2 2026 Earnings Call: Pricing, Market Share Recovery and Deleveraging](https://longbridge.com/en/news/295903765.md) - [Nomad Foods (NYSE:NOMD) Releases FY 2026 Earnings Guidance](https://longbridge.com/en/news/295789845.md) - [NOMD: Q2 results beat expectations; guidance held, but EPS outlook cut on higher interest expense](https://longbridge.com/en/news/295856377.md) - [NOMD: Retail disruptions resolved; margin growth and leadership changes support a stronger outlook](https://longbridge.com/en/news/295809694.md)